PMID: 9537972May 13, 1998Paper

Acute neurologic complications of drug and alcohol abuse

Neurologic Clinics
J C Brust

Abstract

Recreationally abused substances include both legal and illegal agents, broadly classified as opioids, psychostimulants, sedatives, cannabis (marijuana), hallucinogens, inhalants, dissociative anesthetics (phencyclidine), anticholinergics, ethanol, and tobacco. These substances are associated with an array of neurological emergencies resulting from overdose, withdrawal, and other medical and neurological complications.

Associated Clinical Trials

References

Apr 1, 1976·The New England Journal of Medicine·J Koch-WeserH Kalant
Mar 1, 1979·Annals of Internal Medicine·E J Khantzian, G J McKenna
Jan 30, 1975·The New England Journal of Medicine·A R HansenL J Fischer
Feb 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·J C Brust, R W Richter
May 1, 1992·Trends in Pharmacological Sciences·W L Woolverton, K M Johnson
Jul 1, 1991·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P GaudreaultI Verdy
Feb 1, 1991·Annals of Emergency Medicine·L R Goldfrank, R S Hoffman
Mar 1, 1990·Neurology·A Pascual-LeoneD C Anderson
Sep 13, 1990·The New England Journal of Medicine·S R LevineJ F Selwa
Nov 1, 1989·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·P PacificoM F Pantarotto
Jun 1, 1989·Diabetes/metabolism Reviews·M Fulop
Dec 1, 1989·Stroke; a Journal of Cerebral Circulation·P B Gorelick
Dec 1, 1989·Stroke; a Journal of Cerebral Circulation·C A Camargo
Aug 1, 1989·Neurology·B K AlldredgeR P Simon
Aug 14, 1987·JAMA : the Journal of the American Medical Association·C Brown, J Osterloh
Nov 14, 1987·Lancet·A D Dick, M G Prentice
Feb 16, 1989·The New England Journal of Medicine·A Urbano-MarquezE Rubin
Dec 15, 1988·Annals of Internal Medicine·D B KudrowG E Mathisen
May 5, 1988·The New England Journal of Medicine·F H Gawin, E H Ellinwood
Jan 1, 1987·Pharmacology & Therapeutics·H G Morton
Sep 15, 1988·The New England Journal of Medicine·S K NgM Susser
Aug 21, 1987·JAMA : the Journal of the American Medical Association·H H Morris, M L Estes
May 1, 1985·Annals of Neurology·R Malouf, J C Brust
Oct 10, 1985·The New England Journal of Medicine·W D Lerner, H J Fallon
May 1, 1968·The American Journal of Psychiatry·J T UngerleiderA Caldwell
Nov 5, 1970·The New England Journal of Medicine·B P CitronB J Haverback
Dec 6, 1973·The New England Journal of Medicine·C ZelsonM Casalino
Mar 1, 1974·Stroke; a Journal of Cerebral Circulation·A N LiebermanJ P Lin
Apr 30, 1970·The New England Journal of Medicine·A T Weil
Jun 20, 1968·The New England Journal of Medicine·D E Espelin, A K Done
Dec 4, 1982·Lancet·E C WoltersB Verbeeten
Aug 1, 1983·Archives of General Psychiatry·H D Abraham
Oct 1, 1983·Neurology·R B LazarA N Daghestani
Jun 1, 1982·Annals of Emergency Medicine·E Bernstein, B M Diskant
Jun 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·L C GoodhartM Anderson
May 1, 1981·Annals of Emergency Medicine·M M McCarronW A Goetz
Jun 1, 1981·Annals of Emergency Medicine·M M McCarronW A Goetz
Jan 1, 1996·Neurology·M DarasB S Koppel
Mar 28, 1996·The New England Journal of Medicine·L N FriedmanT R Frieden
Jun 1, 1996·Stroke; a Journal of Cerebral Circulation·S G Wannamethee, A G Shaper
Feb 20, 1997·The New England Journal of Medicine·A R KriegsteinP Y Kim
Feb 1, 1997·Neurology·A I QureshiM R Frankel
Jan 11, 1958·Journal of the American Medical Association·H F FRASERH ISBELL

❮ Previous
Next ❯

Citations

Aug 11, 2007·Neuropsychology Review·Karen D Ersche, Barbara J Sahakian
Aug 6, 2003·Life Sciences·Jing-Huei LeeNora D Volkow
Mar 28, 2002·Pharmacology & Therapeutics·S Rahman, M F Miles
May 8, 2000·Social Science & Medicine·M T FrenchC B McCoy
Apr 30, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Susanne WatkinsRobin S Howard
Dec 18, 2013·Annals of Indian Academy of Neurology·P SandeepK C Ajitha
Nov 15, 2006·Intensive Care Medicine·Sébastien OuimetYoanna Skrobik
Jul 22, 2010·Pharmaceuticals·Thierry Favrod-Coune, Barbara Broers
Nov 27, 2010·Emergency Medicine Clinics of North America·David McMicken, Jonathan L Liss
Jun 28, 2006·The European Journal of Neuroscience·Olayinka A DinaJon D Levine
Aug 18, 2006·Addictive Behaviors·Ruth SpinksRemi Cadoret
Apr 14, 2006·Cadernos de saúde pública·Elize Massard da FonsecaFrancisco I Bastos
Nov 8, 2001·Substance Use & Misuse·C B McCoyC Miles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.